First, it was retrospective, which means it relied on patients recalling their experiences months laterthis is far less reliable than a controlled, prospective study
Reich N, Hlscher C (2024) Cholecystokinin (CCK): a neuromodulator with therapeutic potential in Alzheimers and Parkinsons disease
His background allows careful oversight of intravenous therapies with attention to safety, dosing, and individual biochemical variation
the Australian National Health and Medical Research Council through project grant 1160517 to T Thomas, Ideas Grant 2010711 to T Thomas, Research Fellowships 1081421 to AK Voss and 1154970 to GK Smyth, and Investigator Grants 1176789 to AK Voss and 1194345 to ME Blewitt
Always consult healthcare professionals before introducing any new supplements to ensure they're appropriate and beneficial